Cite
HARVARD Citation
Tsuji, S. et al. (2014). AB0449 Baseline Procalcitonin (PCT) Level as A Predictive Marker for Clinical Remission (DAS28-ESR, CDAI) at 52 Weeks in Biologic NaÏVe Rheumatoid Arthritis (RA) Patients Treated by TOCILIZUMAB (TCZ); A Single Center Retrospective Study. Annals of the rheumatic diseases. pp. 956-957. [Online].